UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Multiple sclerosis, 2008-11, Vol.14 (9), p.1157-1174

2008

Volltextzugriff (PDF)

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

Neurology, 2011-05, Vol.76 (22), p.1858

2011

Volltextzugriff (PDF)

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

Neurology, 2007-04, Vol.68 (17), p.1390

2007

Volltextzugriff (PDF)

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Neurology, 2002-01, Vol.58 (2), p.169

2002

Volltextzugriff (PDF)

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

Multiple sclerosis, 2010-11, Vol.16 (11), p.1385-1392

2010

Volltextzugriff (PDF)

Axonal water fraction as marker of white matter injury in primary‐progressive multiple sclerosis: a longitudinal study

European journal of neurology, 2019-08, Vol.26 (8), p.1068-1074

2019

Volltextzugriff (PDF)

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

Neurology, 2008-07, Vol.71 (4), p.265

2008

Volltextzugriff (PDF)

Assessing disability progression with the Multiple Sclerosis Functional Composite

Multiple sclerosis, 2009-08, Vol.15 (8), p.984-997

2009

Volltextzugriff (PDF)

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

Neurology, 2007-04, Vol.68 (16), p.1299

2007

Volltextzugriff (PDF)

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a

Neurology, 2009-06, Vol.72 (23), p.1989

2009

Volltextzugriff (PDF)

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis

Annals of neurology, 1996-01, Vol.39 (1), p.6-16

1996

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

The New England journal of medicine, 2006-03, Vol.354 (9), p.899-910

2006

Volltextzugriff (PDF)

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Journal of neurology, 2009-03, Vol.256 (3), p.405-415

2009

Volltextzugriff (PDF)

Infusion-related hypersensitivity reactions during natalizumab treatment

Neurology, 2006-11, Vol.67 (9), p.1717

2006

Volltextzugriff (PDF)

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference

Neurology, 1996-01, Vol.46 (1), p.12

1996

Volltextzugriff (PDF)

Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters

Radiology, 1995-06, Vol.195 (3), p.725

1995

Volltextzugriff (PDF)

Proof of concept studies for tissue-protective agents in multiple sclerosis

Multiple sclerosis, 2009-05, Vol.15 (5), p.542-546

2009

Volltextzugriff (PDF)

Clinical characteristics of progressive relapsing multiple sclerosis

Multiple sclerosis, 2004-08, Vol.10 (4), p.451-454

2004

Volltextzugriff (PDF)

The genetics of multiple sclerosis. A review

Biomedicine & pharmacotherapy, 1999-09, Vol.53 (8), p.358-370

1999

Volltextzugriff (PDF)

Mitochondrial DNA mutations in multiple sclerosis

Multiple sclerosis, 1995-04, Vol.1 (1), p.32-36

1995

Volltextzugriff (PDF)

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1134

2008

Volltextzugriff (PDF)

Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis

Journal of the American Academy of Dermatology, 1996-02, Vol.34 (2), p.365-367

1996

Volltextzugriff (PDF)

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

Multiple sclerosis and related disorders, 2012-04, Vol.1 (2), p.81-86

2012

Volltextzugriff (PDF)

Therapeutic approaches to secondary progressive multiple sclerosis

Multiple sclerosis, 2002-02, Vol.8 (1), p.88-90

Lublin, F D

2002

Volltextzugriff (PDF)

Characterization of the mitochondrial DNA in patients with multiple sclerosis

Journal of the neurological sciences, 1996-09, Vol.140 (1), p.75-84

1996

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(140)

Publikationsform

Artikel
(194)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(134)
Life Sciences & Biomedicine
(129)
Humans
(117)
Neurosciences & Neurology
(93)
Biological And Medical Sciences
(80)
Clinical Neurology
(78)
Female
(65)
Male
(61)
Medical Sciences
(60)
Neurosciences
(56)
Animals
(54)
Adult
(52)
Neurology
(51)
Middle Aged
(43)
Mice
(38)
Multiple Sclerosis
(34)
Magnetic Resonance Imaging
(28)
Immunology
(23)
Multiple Sclerosis - Drug Therapy
(23)
Fundamental And Applied Biological Sciences. Psychology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

Axonal water fraction as marker of white matter injury in primary‐progressive multiple sclerosis: a longitudinal study

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

Assessing disability progression with the Multiple Sclerosis Functional Composite

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Infusion-related hypersensitivity reactions during natalizumab treatment

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference

Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters

Proof of concept studies for tissue-protective agents in multiple sclerosis

Clinical characteristics of progressive relapsing multiple sclerosis

The genetics of multiple sclerosis. A review

Mitochondrial DNA mutations in multiple sclerosis

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

Therapeutic approaches to secondary progressive multiple sclerosis

Characterization of the mitochondrial DNA in patients with multiple sclerosis

Suchergebnisse filtern